Pembrolizumab,Lenvatinib,Sunitinib,Everolimus,Nivolumab,Ipilimumab,Cabozantinib,Axitinib
Merck,Pfizer,eisai,bms
[' ipi ']
updated io combo table after #asco2023 io/tki presentations. vegf tx provides early disease control while ipi provides durability. we need a way to harness the benefits of both approaches. 